| Document Date: 2014-12-17 12:02:11 Open Document File Size: 3,10 MBShare Result on Facebook
City Washington D.C. / / Company Amarin Pharma Inc. / Case / Amarin Pharmaceuticals Ireland Limited / / Country United States / / Event FDA Phase / / Facility New Hampshire Ave Building / / IndustryTerm fish oil / chemical entity / Diabetes Care / chemical / pharmaceutical / / MedicalCondition disease / Atherosclerosis / hypertriglyceridemia / hyperlipidemia / metabolic syndrome / treated hypertension / / MedicalTreatment dialysis / / Organization Congress / Food and Drug Administration / DHA / DEPARTMENT OF HEALTH / Environmental Protection Agency / / Person Elizabeth H. Dickinson / Silver Spring / Dormer Hyman / Robert A. Dormer / Robert A. Dormer Hyman / Eric Colman / Steven K. Galson / / Position Major / General / / Product Lovaza / Premarin / Vascepa / NDA202057 / Omega-3 / Vascepa (icosapent ethyl) Capsules / previously approved drug / / ProvinceOrState Maryland / / Technology pharmacokinetics / http / pdf / dialysis / / URL http /
SocialTag |